Clinical Trial

Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn to compare the safety and efficacy of virtual ileostomy versus diverting ileostomy in patients undergoing sphincter-saving surgery for rectal cancer. The main questions it aims to answer are: * Is the virtual ileostomy a safe and effective alternative to the ileostomy? * Is it scientifically reasonable to perform diverting ileostomy intraoperatively? Researchers will compare virtual ileostomy to diverting ileostomy to see if the virtual ileostomy works to reduce rates of stoma. Participants will: * Performing diverting ileostomy or virtual ileostomy undergoing sphincter-saving surgery for rectal cancer * Continuous follow-up of their complications after the first surgery
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-07.
Status change: Not Yet Recruiting → Recruiting 2024-10-14
Trial Details
NCT Number NCT06633133
Lead Sponsor Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Conditions Rectal Cancer
Enrollment 620 participants
Start Date 2024-10-10
Primary Completion 2026-12-01 (estimated)
Study Completion 2030-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-16